Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 3 medicines
CBG-MEB · 3 medicines
PHARMAC · 2 medicines
SFDA · 2 medicines · Historical list
TFDA · 2 medicines · Historical list
MS · 1 medicine · Historical list
HSA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
3 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| EULITOP 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 200 mg | comprimido recubierto con película | Marketed | Aurovitas Spain, S.A.U. |
| EULITOP RETARD 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA | Spain | 400 mg | comprimido de liberación prolongada | Marketed | Aurovitas Spain, S.A.U. |
| DIFATEROL RETARD 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA | Spain | 400 mg | comprimido de liberación prolongada | Withdrawn | Laboratorios Bial S.A. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
